HCL Tech to acquire Merck unit C3i Solutions for $60 mn

Life sciences and consumer services provider C3i Solutions which is the subsidiary of US-based drug maker Merck & Co. has received acquisition confirmation from IT firm HCL Technologies for $60 million (Rs 390 crore) in cash, the company said in a stock-exchange disclosure.

HCL Technologies will acquire 100% stake in C3i Solutions.

As per the disclosure, C3i Solutions’ clinical, sales support, and pharmacovigilance expertise, along with its roster of life sciences clients that include 30 of the top pharmaceutical companies, would boost HCL’s life sciences vertical.

C3i Solutions is the business name of Telerx Marketing, a wholly-owned subsidiary of Merck & Co. The revenue of C3i Solutions stood at $199 million in the year through December 2017. C3i has a workforce of over 3,700 employees across 11 facilities in India, the US, Bulgaria, China, the UK, and Japan.